NOTV
Inotiv, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.08
+121.94%Year over year
Reported trailing growth
- Revenue
- +5.6%
- EBITDA
- +80.4%
- EBIT
- +14.0%
- EPS
- +20.7%
- Free cash flow
- +74.9%
- Operating cash flow
- +101.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.2%
- EBITDA
- +192.5%
- EBIT
- +64.2%
- Net income
- +36.7%
- EPS
- +49.6%
- Free cash flow
- +7.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026